Pertussis vaccine effectiveness following country-wide implementation of a hexavalent acellular pertussis immunization schedule in infants and children in Panama-Reference-Cited by-同舟云学术

Pertussis vaccine effectiveness following country-wide implementation of a hexavalent acellular pertussis immunization schedule in infants and children in Panama

Published:2024-08-20 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Calvo Arlene E.¹²^ORCID,Tristán Urrutia Andrea G.³,Vargas-Zambrano Juan C.⁴,López Castillo Humberto⁵⁶

Affiliation:

1. College of Public Health, University of South Florida, Panama Program at City of Knowledge, Tampa, FL, USA

2. Gorgas Memorial Institute for Health Studies, Panama City, Panama

3. Rollins School of Public Health, Emory University, Atlanta, GA, USA

4. Global Medical Vaccines, Sanofi, Lyon, France

5. Department of Health Sciences, College of Health Professions and Sciences, Academic Health Sciences Center, University of Central Florida, Orlando, FL, USA

6. Department of Population Health Sciences, College of Medicine, Academic Health Sciences Center, University of Central Florida, Orlando, FL, USA

Funder

Sanofi

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2389577

Reference30 articles.

1. World Health Organization. Health topics pertussis.

2. Clinically Diagnosing Pertussis-associated Cough in Adults and Children

3. Centers for Disease Control and Prevention. Pertussis | La tos ferina | Causas y transmisión. Centro Nacional de Vacunación y Enfermedades Respiratorias División de Enfermedades Bacterianas. 2017.

4. Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update

5. World Health Organization. Pertussis vaccines: WHO position paper - August 2015. Weekly epidemiological record. 2015: 1–28.